Total Payments
$159,687
2021 Payments
$109.80
Companies
6
Transactions
228
Payment Breakdown by Category
Other$142,085 (89.0%)
Travel$12,792 (8.0%)
Food & Beverage$4,271 (2.7%)
Consulting$442.50 (0.3%)
Gifts$93.50 (0.1%)
Education$3.35 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $142,085 | 64 | 89.0% |
| Travel and Lodging | $12,792 | 87 | 8.0% |
| Food and Beverage | $4,271 | 73 | 2.7% |
| Consulting Fee | $442.50 | 1 | 0.3% |
| Gift | $93.50 | 2 | 0.1% |
| Education | $3.35 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $106,071 | 165 | $0 (2020) |
| Alkermes, Inc. | $49,598 | 52 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $3,650 | 7 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $150.39 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $108.81 | 1 | $0 (2019) |
| Allergan Inc. | $108.12 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $109.80 | 1 | Otsuka America Pharmaceutical, Inc. ($109.80) |
| 2020 | $2,800 | 3 | Sunovion Pharmaceuticals Inc. ($2,800) |
| 2019 | $17,003 | 25 | Sunovion Pharmaceuticals Inc. ($16,828) |
| 2018 | $71,057 | 104 | Sunovion Pharmaceuticals Inc. ($50,656) |
| 2017 | $68,716 | 95 | Sunovion Pharmaceuticals Inc. ($35,786) |
All Payment Transactions
228 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/15/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $109.80 | General |
| Category: PSYCHIATRY | ||||||
| 11/24/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: CNS | ||||||
| 09/29/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: CNS | ||||||
| 06/04/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: CNS | ||||||
| 11/21/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,030.00 | General |
| Category: CNS | ||||||
| 11/21/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $84.68 | General |
| Category: CNS | ||||||
| 11/12/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,055.00 | General |
| Category: CNS | ||||||
| 11/12/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | In-kind items and services | $406.59 | General |
| Category: CNS | ||||||
| 11/12/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | In-kind items and services | $216.45 | General |
| Category: CNS | ||||||
| 11/12/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $98.86 | General |
| Category: CNS | ||||||
| 11/12/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $22.00 | General |
| Category: CNS | ||||||
| 11/12/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| Category: CNS | ||||||
| 11/12/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $3.84 | General |
| Category: CNS | ||||||
| 10/22/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,684.00 | General |
| Category: CNS | ||||||
| 10/22/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $47.56 | General |
| Category: CNS | ||||||
| 10/22/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: CNS | ||||||
| 09/24/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $108.81 | General |
| Category: Neuroscience | ||||||
| 09/19/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,255.00 | General |
| Category: CNS | ||||||
| 09/19/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $141.52 | General |
| Category: CNS | ||||||
| 09/19/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $37.48 | General |
| Category: CNS | ||||||
| 07/17/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: CNS | ||||||
| 07/17/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $110.10 | General |
| Category: CNS | ||||||
| 06/20/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: CNS | ||||||
| 06/20/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $244.76 | General |
| Category: CNS | ||||||
| 06/20/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Travel and Lodging | Cash or cash equivalent | $180.47 | General |
| Category: CNS | ||||||
About Dr. John Pankiewicz, M.D
Dr. John Pankiewicz, M.D is a Forensic Psychiatry healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023142064.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Pankiewicz, M.D has received a total of $159,687 in payments from pharmaceutical and medical device companies, with $109.80 received in 2021. These payments were reported across 228 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($142,085).
Ad
Practice Information
- Specialty Forensic Psychiatry
- Location Milwaukee, WI
- Active Since 03/14/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084F0202X
- Entity Type Individual
- NPI Number 1023142064
Products in Payments
- LATUDA (Drug) $106,071
- Aristada 441 mg (Drug) $49,558
- REXULTI (Drug) $109.80
- SPRAVATO (Drug) $108.81
- VRAYLAR (Drug) $108.12
- Vivitrol 380 mg (Drug) $40.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.